The Hartford Healthcare Fund Class R3
HGHRX
NASDAQ
| Weiss Ratings | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Hartford Mutual Funds | |||
| Manager/Tenure (Years) | Rebecca Sykes (4) | |||
| Website | http://www.hartfordfunds.com | |||
| Fund Information | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | The Hartford Healthcare Fund Class R3 | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 22, 2006 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.21% | |||
| Asset Allocation | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 2.25% | |||
| Stock | 97.75% | |||
| U.S. Stock | 90.58% | |||
| Non-U.S. Stock | 7.17% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.79% | |||
| 30-Day Total Return | 2.63% | |||
| 60-Day Total Return | -2.87% | |||
| 90-Day Total Return | -6.14% | |||
| Year to Date Total Return | -5.61% | |||
| 1-Year Total Return | -12.03% | |||
| 2-Year Total Return | -2.87% | |||
| 3-Year Total Return | 3.06% | |||
| 5-Year Total Return | 11.75% | |||
| Price | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $33.45 | |||
| 1-Month Low NAV | $32.59 | |||
| 1-Month High NAV | $33.93 | |||
| 52-Week Low NAV | $32.09 | |||
| 52-Week Low NAV (Date) | May 14, 2025 | |||
| 52-Week High NAV | $43.41 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.58 | |||
| Standard Deviation | 14.22 | |||
| Balance Sheet | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 796.39M | |||
| Operating Ratios | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.63% | |||
| Turnover Ratio | 40.00% | |||
| Performance | HGHRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 3.96% | |||
| Last Bear Market Total Return | -9.63% | |||